New insights into cholesterol‐mediated ERRα activation in breast cancer progression and pro‐tumoral microenvironment orchestration-Reference-Cited by-同舟云学术

New insights into cholesterol‐mediated ERRα activation in breast cancer progression and pro‐tumoral microenvironment orchestration

Published:2022-10-26 Issue:6 Volume:290 Page:1481-1501
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:The FEBS Journal

Author:

Brindisi Matteo¹²^ORCID,Frattaruolo Luca¹^ORCID,Fiorillo Marco¹³^ORCID,Dolce Vincenza¹^ORCID,Sotgia Federica³^ORCID,Lisanti Michael P.³^ORCID,Cappello Anna Rita¹^ORCID

Affiliation:

1. Department of Pharmacy, Health and Nutritional Sciences University of Calabria Rende Italy

2. Cell Adhesion Unit Vita‐Salute San Raffaele University Milan Italy

3. Translational Medicine, School of Science, Engineering and the Environment (SEE) University of Salford Greater Manchester UK

Funder

Regione Calabria

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.16651

Reference84 articles.

1. Lipid metabolism reprogramming and its potential targets in cancer

2. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis

3. Breast cancer precursors revisited: molecular features and progression pathways

4. Nuclear receptors in cancer — uncovering new and evolving roles through genomic analysis

5. The nuclear receptor superfamily

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of De Novo Cholesterol Biosynthesis on the Initiation and Progression of Breast Cancer;Biomolecules;2024-01-03

3. FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity;Cells;2023-12-06

4. Advances in Medicinal Chemistry of Estrogen-related Receptor Alpha (ERRα) Inverse Agonists;Current Topics in Medicinal Chemistry;2023-08-10

5. Metabolic switching of estrogen‐related receptor alpha in breast cancer aggression;The FEBS Journal;2023-02-28